Pharma News

Breaking New Ground: Study Reveals Myeloma Cells Create Unique Microenvironments, Challenging a Uniform Treatment Approach

Breaking New Ground: Study Reveals Myeloma Cells Create Unique Microenvironments, Challenging a Uniform Treatment Approach

Pharm'Up

A new and groundbreaking study published in the journal Blood is set to redefine our understanding of...

Unicycive Therapeutics Secures US Patent for UNI-494 to Treat Chronic Kidney Disease

Unicycive Therapeutics Secures US Patent for UNI-494 to Treat Chronic Kidney Disease

Pharm'Up

Unicycive Therapeutics has announced that it has been issued a new U.S. patent for its investigational drug,...

US Pharmacy Landscape Undergoing Major Shift as Customers Favor Mail-Order and Supermarkets Over Chain Drugstores

US Pharmacy Landscape Undergoing Major Shift as Customers Favor Mail-Order and Supermarkets Over Chain Drugstores

Pharm'Up

A new report, the 2025 U.S. Pharmacy Study by J.D. Power, reveals a significant change in how...

Bridging the Divide: How Community Oncology is Advancing Precision Medicine

Bridging the Divide: How Community Oncology is Advancing Precision Medicine

Pharm'Up

Precision medicine is no longer a futuristic concept—it is at the forefront of modern cancer care, with...

Pharmacists Poised to Lead Precision Oncology, But Barriers Hinder Progress

Pharmacists Poised to Lead Precision Oncology, But Barriers Hinder Progress

Pharm'Up

In a presentation at the 2025 Oncology Pharmacists Connect (OPC) meeting, Mya Tran, PharmD, BCOP, highlighted a...

COVID-19 Pandemic Worsened Cardiovascular Screening Disparities for Adults with Disabilities

COVID-19 Pandemic Worsened Cardiovascular Screening Disparities for Adults with Disabilities

Pharm'Up

A new study published in the American Journal of Preventive Medicine highlights that the COVID-19 pandemic exacerbated...

New Alaska Law Limits Prior Authorization Decision Times

New Alaska Law Limits Prior Authorization Decision Times

Pharm'Up

Alaska passed SB 133, a new law that places strict time limits on prior authorization (PA) decisions...

Novo Nordisk’s Wegovy Secures Landmark Accelerated USFDA Approval for MASH, Positioning It as First GLP-1 Therapy for Liver Disease

Novo Nordisk’s Wegovy Secures Landmark Accelerated USFDA Approval for MASH, Positioning It as First GLP-1 Therapy for Liver Disease

Pharm'Up

Novo Nordisk has received final approval from the U.S. Food and Drug Administration (FDA) for a new...

Vanda Wins Appeal to Overturn FDA Denial for Hetlioz

Vanda Wins Appeal to Overturn FDA Denial for Hetlioz

Pharm'Up

This victory for Vanda (case no. 24-1049) culminates a long-running dispute that began in October 2018 when...

Headaches and Hematology: Differentiating Benign vs. Life-Threatening Headaches in PNH Patients

Headaches and Hematology: Differentiating Benign vs. Life-Threatening Headaches in PNH Patients

Pharm'Up

Headaches are a common side effect for patients taking complement inhibitors for paroxysmal nocturnal hemoglobinuria (PNH), a...